News
TEVIMBRA approved in U.S. for first-line treatment of advanced esophageal squamous cell carcinoma in...
The U.S. Food and Drug Administration (FDA) has approved BeiGene's TEVIMBRA (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the first-line treatment of adults with...
Sun Pharma to acquire Checkpoint Therapeutics
Sun Pharmaceutical Industries has entered into an agreement to acquire Checkpoint Therapeutics, an immunotherapy and targeted oncology company.
Checkpoint is a Nasdaq-listed commercial-stage company focused...
WAINZUA approved in EU for hereditary transthyretin-mediated amyloidosis in adults with stage 1 or...
Ionis Pharmaceuticals and AstraZeneca’s WAINZUA (eplontersen) has been approved in the European Union (EU) for the treatment of hereditary transthyretin-mediated amyloidosis in adult patients...
